EraCal Therapeutics Ltd

For any other company, spending €235m ($256m) on a preclinical program with an unproven mechanism might be a punchy move. But Novo Nordisk A/S has money to burn thanks to its wildly successful diabe

Evotec SE has inked a drug discovery and development partnership with Eli Lilly and Company worth up to $1bn, adding to its history of metabolic disease-focused deal making. The collaboration will